Joseph Lasaga
Corporate Officer/Principal at RIGEL PHARMACEUTICALS, INC.
Profile
Joseph Lasaga is a Senior Vice President-Corporate Development at Rigel Pharmaceuticals, Inc. He previously worked as a Senior Director-Business Development at Nektar Therapeutics from 2010 to 2014 and as a VP-Business Development & Alliance Management at Galena Biopharma, Inc. from 2014 to 2016.
Joseph holds an MBA from San Francisco State University and an undergraduate degree from San Jose State University.
Joseph Lasaga active positions
| Companies | Position | Start |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 1997-12-31 |
Former positions of Joseph Lasaga
| Companies | Position | End |
|---|---|---|
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Corporate Officer/Principal | 2016-09-30 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 2014-07-31 |
Training of Joseph Lasaga
| San Francisco State University | Masters Business Admin |
| San Jose State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| Private companies | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Stock Market
- Insiders
- Joseph Lasaga
